Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
US8401641B2 · kind B2 · utility
1Cited by
16References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2011 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | Nov 7, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/395
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
To control cardiac arrhythmias such as atrial fibrillation post-operatively, various non-ablative agents include polymers, fibroblasts, neurotoxins, and growth factors are introduced into one or more cardiac fat pads into the atrioventricular nodal fat pad in proximity to the autonomic ganglia therein. Any desired technique may be used for introducing the agent, including injection. The sinoatrial nodal fat pad target site and the atrioventricular nodal fat pad target site are identified using a stimulator, which may have electrodes coupled thereto or which may coupled to electrodes built into a delivery system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.